HALOZYME THERAPEUTICS INC (27)

Browse by Contract Category

Contracts

Amendment No. 1 to the Credit Agreement (Filed With SEC on August 19, 2022)
Form of Capped Call Confirmation (Filed With SEC on August 18, 2022)
Agreement for Assignment and Assumption of Lease, Del Mar Corporate Centre I Office Lease and First Amendment to Office Lease (Filed With SEC on May 10, 2022)
Agreement and Plan of Merger, dated as of April 12, 2022, by and among Halozyme Therapeutics, Inc., Atlas Merger Sub, Inc. and Antares Pharma, Inc (Filed With SEC on April 13, 2022)
Halozyme Therapeutics, Inc Directors Deferred Equity Compensation Plan (Filed With SEC on February 22, 2022)
Indenture, dated August 18, 2022 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on August 18, 2022)
Security Agreement, dated as of May 24, 2022, by and among Halozyme Therapeutics, Inc., the Guarantors and Bank of America N.A (Filed With SEC on May 24, 2022)
Credit Agreement, dated as of May 24, 2022, by and among Halozyme Therapeutics, Inc., the Guarantors, Bank of America N.A. and each of those additional Lenders that are a party to... (Filed With SEC on May 24, 2022)
Halozyme Therapeutics, Inc. Non Qualified Deferred Compensation Plan Adoption Agreement (Filed With SEC on February 22, 2022)
Description of Securities (Filed With SEC on February 22, 2022)
Form of Restricted Stock Units Agreement for Irish Participants (2021 Stock Plan) (Filed With SEC on August 9, 2021)
Form of Performance Stock Units Agreement (2021 Stock Plan) (Filed With SEC on May 5, 2021)
Form of Director Restricted Stock Units Agreement (2021 Stock Plan) (Filed With SEC on May 5, 2021)
Form of Restricted Stock Award Agreement (2021 Stock Plan) (Filed With SEC on May 5, 2021)
Form of Restricted Stock Units Agreement (2021 Stock Plan) (Filed With SEC on May 5, 2021)
Form of Restricted Stock Units Agreement for Officers (2021 Stock Plan) (Filed With SEC on May 5, 2021)
Form of Stock Option Agreement (2021 Stock Plan) (Filed With SEC on May 5, 2021)
Halozyme Therapeutics, Inc. 2021 Stock Plan (Filed With SEC on May 5, 2021)
Halozyme Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on May 5, 2021)
Form of Note, dated March 1, 2021 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on March 1, 2021)
Indenture, dated March 1, 2021 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on March 1, 2021)
Form of PSU Agreement (Filed With SEC on February 23, 2021)
Form of Performance Stock Units Agreement Under the Halozyme Therapeutics, Inc 2011 Stock Plan (Filed With SEC on August 10, 2020)
Description of Securities (Filed With SEC on February 24, 2020)
Form of Note, dated November 18, 2019 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A, as trustee (Filed With SEC on November 18, 2019)
Indenture, dated November 18, 2019 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A, as trustee (Filed With SEC on November 18, 2019)
Third Amendment to Loan and Security Agreement between Oxford, SVB and Registrant, dated June 14, 2019 (Filed With SEC on August 6, 2019)